@article{441815d31d78455dbab41112322e433a,
title = "Are antibodies directed against amyloid-β (Aβ) oligomers the last call for the Aβ hypothesis of Alzheimer's disease?",
abstract = "N/A",
keywords = "Alzheimer's disease, BAN2401, Immunology, Immunology and Allergy, MCI, Oncology, aducanumab, dementia, monoclonal antibodies, passive immunotherapy, prodromal Alzheimer's disease, Alzheimer's disease, BAN2401, Immunology, Immunology and Allergy, MCI, Oncology, aducanumab, dementia, monoclonal antibodies, passive immunotherapy, prodromal Alzheimer's disease",
author = "Antonio Daniele and Francesco Panza and Madia Lozupone and Vittorio Dibello and Antonio Greco and Davide Seripa and Giancarlo Logroscino and Imbimbo, {Bruno P}",
year = "2019",
doi = "10.2217/imt-2018-0119",
language = "English",
volume = "11",
pages = "3--6",
journal = "Immunotherapy",
issn = "1750-743X",
publisher = "London : Future Medicine, 2009-",
}